New Study Reveals Osteoporosis Medications May Not Prevent Osteoarthritis
Osteoporosis Medication May Not Protect You Against Osteoarthritis: Study
Ndtv
Image: Ndtv
A recent study published in the BMJ Journal indicates that medications commonly prescribed for osteoporosis, specifically oral bisphosphonates, do not significantly lower the risk of developing osteoarthritis. This finding emphasizes the need for distinct management strategies for these two prevalent age-related conditions.
- 01Oral bisphosphonates do not significantly reduce the risk of osteoarthritis in osteoporosis patients.
- 02Previous theories suggested bisphosphonates might protect joint health, but new findings challenge this.
- 03Osteoporosis and osteoarthritis affect many older adults simultaneously, complicating treatment.
- 04Effective management of osteoarthritis requires separate strategies beyond osteoporosis medications.
- 05Bisphosphonates remain effective for reducing fracture risk in osteoporosis when used appropriately.
Advertisement
In-Article Ad
A recent study published in the BMJ Journal has found that oral bisphosphonates, medications commonly prescribed for osteoporosis, do not significantly reduce the risk of developing osteoarthritis. This research challenges previous assumptions that these drugs could also benefit joint health. Osteoporosis and osteoarthritis frequently coexist in older adults, with osteoarthritis affecting an estimated 528 million people globally in 2019. Bisphosphonates, including Alendronate, Risedronate, Ibandronate, and Zoledronate, are primarily used to strengthen bones and reduce fracture risk. The study highlights the need for distinct treatment strategies for managing osteoarthritis, which remains a leading cause of pain and disability worldwide. Experts recommend that individuals with osteoporosis continue their prescribed treatments while also focusing on joint health through weight management, exercise, and physiotherapy.
Advertisement
In-Article Ad
The findings suggest that older adults with osteoporosis need to manage their joint health separately, which could lead to increased healthcare needs and lifestyle adjustments.
Advertisement
In-Article Ad
Reader Poll
Do you think osteoporosis medications should also address joint health?
Connecting to poll...
Read the original article
Visit the source for the complete story.